Harveshp D Mogal1, Marissa Howard-McNatt1, Rebecca Dodson1, Nora F Fino2, Clancy J Clark3. 1. Division of Surgical Oncology, Department of General Surgery, Wake Forest University Baptist Medical Center, Medical Center Blvd., Winston-Salem, NC, 27157, USA. 2. Department of Biostatistical Sciences, Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA. 3. Division of Surgical Oncology, Department of General Surgery, Wake Forest University Baptist Medical Center, Medical Center Blvd., Winston-Salem, NC, 27157, USA. cjclark@wakehealth.edu.
Abstract
INTRODUCTION: Factors associated with lower health-related quality of life (HRQOL) among older African American (AA) breast cancer survivors (BCS) have not been elucidated. METHODS: Using the Surveillance, Epidemiology, and End Results-Medicare Health Outcome Survey linked dataset, all resected AA BCS over 65 were identified. Using the most recent survey after diagnosis, individuals with a VR12 physical (PCS) or mental (MCS) component score 10 points lower than the median were categorized as having poor HRQOL. Univariate and multivariate (MV) analyses identified predictors of poor HRQOL. RESULTS: Of 373 AA BCS (median age 74.6), median time from diagnosis to survey was 68.4 months with median follow-up of 138.6 months. Median PCS was 35.9 (IQR 28.5-44.5) with 76 (20.1%) reporting poor PCS. Median MCS was 50.6 (IQR 41.3-59.1) with 101 (27.1%) reporting poor MCS. Predictors of poor PCS included advanced age, larger tumor size, ≥2 comorbidities, inability to perform >2 of 6 activities of daily living (ADLs), modified/radical mastectomy, infiltrating lobular carcinoma, and stage III or IV disease (all p < 0.05). Comorbidities ≥2 and inability to perform >2 of 6 ADLs (p < 0.05) predicted poor MCS. Inability to perform >2 of 6 ADLs was the only independent predictor of poor PCS (OR 10.9, 95% CI 3.0-39.3; p < 0.001) and MCS (OR 7.6, 95% CI 4.3-13.3; p < 0.001). CONCLUSION: In elderly AA BCS, poor HRQOL was not associated with socioeconomic status or tumor-specific factors but rather impairment in ADLs. Physical and mental HRQOL in African American breast cancer survivors is not dependent on socioeconomic or tumor-related characteristics, but rather on inability to perform ADLs.
INTRODUCTION: Factors associated with lower health-related quality of life (HRQOL) among older African American (AA) breast cancer survivors (BCS) have not been elucidated. METHODS: Using the Surveillance, Epidemiology, and End Results-Medicare Health Outcome Survey linked dataset, all resected AA BCS over 65 were identified. Using the most recent survey after diagnosis, individuals with a VR12 physical (PCS) or mental (MCS) component score 10 points lower than the median were categorized as having poor HRQOL. Univariate and multivariate (MV) analyses identified predictors of poor HRQOL. RESULTS: Of 373 AA BCS (median age 74.6), median time from diagnosis to survey was 68.4 months with median follow-up of 138.6 months. Median PCS was 35.9 (IQR 28.5-44.5) with 76 (20.1%) reporting poor PCS. Median MCS was 50.6 (IQR 41.3-59.1) with 101 (27.1%) reporting poor MCS. Predictors of poor PCS included advanced age, larger tumor size, ≥2 comorbidities, inability to perform >2 of 6 activities of daily living (ADLs), modified/radical mastectomy, infiltrating lobular carcinoma, and stage III or IV disease (all p < 0.05). Comorbidities ≥2 and inability to perform >2 of 6 ADLs (p < 0.05) predicted poor MCS. Inability to perform >2 of 6 ADLs was the only independent predictor of poor PCS (OR 10.9, 95% CI 3.0-39.3; p < 0.001) and MCS (OR 7.6, 95% CI 4.3-13.3; p < 0.001). CONCLUSION: In elderly AA BCS, poor HRQOL was not associated with socioeconomic status or tumor-specific factors but rather impairment in ADLs. Physical and mental HRQOL in African American breast cancer survivors is not dependent on socioeconomic or tumor-related characteristics, but rather on inability to perform ADLs.
Entities:
Keywords:
African American; Breast cancer survivor; HRQOL; MCS; PCS
Authors: Laura C Pinheiro; Stephanie B Wheeler; Ronald C Chen; Deborah K Mayer; Jessica C Lyons; Bryce B Reeve Journal: Cancer Date: 2014-12-18 Impact factor: 6.860
Authors: Joan M Neuner; Nathan Zokoe; Emily L McGinley; Liliana E Pezzin; Tina W F Yen; Marilyn M Schapira; Ann B Nattinger Journal: Breast Date: 2014-07-14 Impact factor: 4.380
Authors: Kathleen W Wyrwich; William M Tierney; Ajit N Babu; Kurt Kroenke; Fredric D Wolinsky Journal: Health Serv Res Date: 2005-04 Impact factor: 3.402
Authors: Kathleen M Russell; Diane M Von Ah; R Brian Giesler; Anna M Storniolo; Joan E Haase Journal: Cancer Nurs Date: 2008 Nov-Dec Impact factor: 2.592
Authors: R J Prescott; I H Kunkler; L J Williams; C C King; W Jack; M van der Pol; T T Goh; R Lindley; J Cairns Journal: Health Technol Assess Date: 2007-08 Impact factor: 4.014
Authors: Angela M Stover; Deborah K Mayer; Hyman Muss; Stephanie B Wheeler; Jessica C Lyons; Bryce B Reeve Journal: Cancer Date: 2014-03-19 Impact factor: 6.860
Authors: Mei R Fu; Deborah Axelrod; Amber A Guth; Charles M Cleland; Caitlin E Ryan; Kristen R Weaver; Jeanna M Qiu; Robin Kleinman; Joan Scagliola; Joseph J Palamar; Gail D'Eramo Melkus Journal: J Pers Med Date: 2015-06-26
Authors: Cathleen Y Xing; Michelle Doose; Bo Qin; Yong Lin; Tiffany L Carson; Jesse J Plascak; Kitaw Demissie; Chi-Chen Hong; Elisa V Bandera; Adana A M Llanos Journal: Breast Cancer Res Treat Date: 2020-09-10 Impact factor: 4.872
Authors: Mohammad Keilani; Franz Kainberger; Anna Pataraia; Timothy Hasenöhrl; Barbara Wagner; Stefano Palma; Fadime Cenik; Richard Crevenna Journal: Wien Klin Wochenschr Date: 2019-07-02 Impact factor: 1.704
Authors: Jéssica Alonso-Molero; Trinidad Dierssen-Sotos; Ines Gomez-Acebo; Nerea Fernandez de Larrea Baz; Marcela Guevara; Pilar Amiano; Gemma Castaño-Vinyals; Tania Fernandez-Villa; Victor Moreno; Juan Bayo; Ana Molina-Barceloa; María Fernández-Ortíz; Claudia Suarez-Calleja; Rafael Marcos-Gragera; Xavier Castells; Leire Gil-Majuelo; Eva Ardanaz; Beatriz Pérez-Gómez; Manolis Kogevinas; Marina Pollán; Javier Llorca Journal: Int J Environ Res Public Health Date: 2020-11-13 Impact factor: 3.390
Authors: Jaidyn Muhandiramge; Suzanne G Orchard; Erica T Warner; Gijsberta J van Londen; John R Zalcberg Journal: Cancers (Basel) Date: 2022-03-08 Impact factor: 6.639